ProMab Biotechnologies has developed a growing list of engineered cell lines including CAR-T/NK cells and target cells, e.g. cancer stem cells. Combining our antibody development and validation technologies, normal cells, iPSC’s, non-cancer stem cells, and cancer stem cells, will be examined to identify unique cancer stem cell markers. We also offer a full line of other CSC-products and services including cancer stem cell media, cancer stem cell antibodies, and more.

The service includes the cell culture of 10 cancer stem cell lines, transplantation of tumor cells in immunocompromised mice, generating recombinant protein, monoclonal antibodies, and extensive validation for $22,500.